153 related articles for article (PubMed ID: 29870276)
1. Upregulation of HOXA10 Protein Expression Predicts Poor Prognosis for Colorectal Cancer.
Yuan Y; Sun S; Jiao N; Shu Y; Zhang Y
Genet Test Mol Biomarkers; 2018 Jun; 22(6):390-397. PubMed ID: 29870276
[TBL] [Abstract][Full Text] [Related]
2. FANCJ expression predicts the response to 5-fluorouracil-based chemotherapy in MLH1-proficient colorectal cancer.
Nakanishi R; Kitao H; Fujinaka Y; Yamashita N; Iimori M; Tokunaga E; Yamashita N; Morita M; Kakeji Y; Maehara Y
Ann Surg Oncol; 2012 Oct; 19(11):3627-35. PubMed ID: 22526901
[TBL] [Abstract][Full Text] [Related]
3. GOLPH3 predicts survival of colorectal cancer patients treated with 5-fluorouracil-based adjuvant chemotherapy.
Wang Z; Jiang B; Chen L; Di J; Cui M; Liu M; Ma Y; Yang H; Xing J; Zhang C; Yao Z; Zhang N; Dong B; Ji J; Su X
J Transl Med; 2014 Jan; 12():15. PubMed ID: 24444035
[TBL] [Abstract][Full Text] [Related]
4. Decreased expression of PinX1 protein predicts poor prognosis of colorectal cancer patients receiving 5-FU adjuvant chemotherapy.
Deng W; Jiao N; Li N; Wan X; Luo S; Zhang Y
Biomed Pharmacother; 2015 Jul; 73():1-5. PubMed ID: 26211574
[TBL] [Abstract][Full Text] [Related]
5. Increased phosphorylation of 4E‑binding protein 1 predicts poor prognosis for patients with colorectal cancer.
Miao Y; Chen L; Shi C; Fan R; Chen P; Liu H; Xia A; Qian H
Mol Med Rep; 2017 May; 15(5):3099-3104. PubMed ID: 28339030
[TBL] [Abstract][Full Text] [Related]
6. Glycolysis is essential for chemoresistance induced by transient receptor potential channel C5 in colorectal cancer.
Wang T; Ning K; Sun X; Zhang C; Jin LF; Hua D
BMC Cancer; 2018 Feb; 18(1):207. PubMed ID: 29463225
[TBL] [Abstract][Full Text] [Related]
7. Predictive role of thymidylate synthase, dihydropyrimidine dehydrogenase and thymidine phosphorylase expression in colorectal cancer patients receiving adjuvant 5-fluorouracil.
Ciaparrone M; Quirino M; Schinzari G; Zannoni G; Corsi DC; Vecchio FM; Cassano A; La Torre G; Barone C
Oncology; 2006; 70(5):366-77. PubMed ID: 17179731
[TBL] [Abstract][Full Text] [Related]
8. Lysosomal acid phosphatase 2 is an unfavorable prognostic factor but is associated with better survival in stage II colorectal cancer patients receiving chemotherapy.
Lee YC; Su CY; Lin YF; Lin CM; Fang CY; Lin YK; Hsiao M; Chen CL
Oncotarget; 2017 Feb; 8(7):12120-12132. PubMed ID: 28076332
[TBL] [Abstract][Full Text] [Related]
9. Expression of the hMLH1 gene is a possible predictor for the clinical response to 5-fluorouracil after a surgical resection in colorectal cancer.
Ide T; Kitajima Y; Ohtaka K; Mitsuno M; Nakafusa Y; Miyazaki K
Oncol Rep; 2008 Jun; 19(6):1571-6. PubMed ID: 18497967
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of HOXA10 promotes gastric cancer cells proliferation and HOXA10(+)/CD44(+) is potential prognostic biomarker for gastric cancer.
Han Y; Lu S; Wen YG; Yu FD; Zhu XW; Qiu GQ; Tang HM; Peng ZH; Zhou CZ
Eur J Cell Biol; 2015 Dec; 94(12):642-52. PubMed ID: 26552644
[TBL] [Abstract][Full Text] [Related]
11. Exploiting a novel miR-519c-HuR-ABCG2 regulatory pathway to overcome chemoresistance in colorectal cancer.
To KK; Leung WW; Ng SS
Exp Cell Res; 2015 Nov; 338(2):222-31. PubMed ID: 26386386
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of CREPT confers colorectal cancer sensitivity to fluorouracil.
Kuang YS; Wang Y; Ding LD; Yang L; Wang Y; Liu SH; Zhu BT; Wang XN; Liu HY; Li J; Chang ZJ; Wang YY; Jia BQ
World J Gastroenterol; 2018 Jan; 24(4):475-483. PubMed ID: 29398868
[TBL] [Abstract][Full Text] [Related]
13. Identification of Genes Related to 5-Fluorouracil Based Chemotherapy for Colorectal Cancer.
Huang X; Ke K; Jin W; Zhu Q; Zhu Q; Mei R; Zhang R; Yu S; Shou L; Sun X; Feng J; Duan T; Mou Y; Xie T; Wu Q; Sui X
Front Immunol; 2022; 13():887048. PubMed ID: 35784334
[TBL] [Abstract][Full Text] [Related]
14. Identification of colorectal cancer patients with tumors carrying the TP53 mutation on the codon 72 proline allele that benefited most from 5-fluorouracil (5-FU) based postoperative chemotherapy.
Godai TI; Suda T; Sugano N; Tsuchida K; Shiozawa M; Sekiguchi H; Sekiyama A; Yoshihara M; Matsukuma S; Sakuma Y; Tsuchiya E; Kameda Y; Akaike M; Miyagi Y
BMC Cancer; 2009 Dec; 9():420. PubMed ID: 19954513
[TBL] [Abstract][Full Text] [Related]
15. Identification of potential pharmacogenomic markers of clinical efficacy of 5-fluorouracil in colorectal cancer.
Nobili S; Napoli C; Landini I; Morganti M; Cianchi F; Valanzano R; Tonelli F; Cortesini C; Mazzei T; Mini E
Int J Cancer; 2011 Apr; 128(8):1935-45. PubMed ID: 20560137
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-544a Regulates Migration and Invasion in Colorectal Cancer Cells via Regulation of Homeobox A10.
Sun S; Su C; Zhu Y; Li H; Liu N; Xu T; Sun C; Lv Y
Dig Dis Sci; 2016 Sep; 61(9):2535-44. PubMed ID: 27165435
[TBL] [Abstract][Full Text] [Related]
17. XRCC2-Deficient Cells are Highly Sensitive to 5-Fluorouracil in Colorectal Cancer.
Zhang YZ; An JH; Liu YX; Wu XC; Han SS; Ren XQ; Qin CJ
Cell Physiol Biochem; 2017; 43(3):1207-1219. PubMed ID: 28977800
[TBL] [Abstract][Full Text] [Related]
18. Down-regulation of SNX1 predicts poor prognosis and contributes to drug resistance in colorectal cancer.
Bian Z; Feng Y; Xue Y; Hu Y; Wang Q; Zhou L; Liu Z; Zhang J; Yin Y; Gu B; Huang Z
Tumour Biol; 2016 May; 37(5):6619-25. PubMed ID: 26643894
[TBL] [Abstract][Full Text] [Related]
19. CAC1 knockdown reverses drug resistance through the downregulation of P-gp and MRP-1 expression in colorectal cancer.
Chen N; Kong Y; Wu Y; Gao Q; Fu J; Sun X; Geng Q
PLoS One; 2019; 14(9):e0222035. PubMed ID: 31504073
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of interaction between somatic APC mutations and 5-fluorouracil adjuvant chemotherapy in Taiwanese colorectal cancer subjects.
Chen SP; Wu CC; Lin SZ; Kang JC; Su CC; Chen YL; Lin PC; Chiu SC; Pang CY; Harn HJ
Am J Clin Oncol; 2009 Apr; 32(2):122-6. PubMed ID: 19307944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
